{"result": "{\n    \"title\": \"Lymphatic System Cancer Treatment Community\",\n    \"summary\": \"The community focuses on Lymphatic System Cancer and its treatment options, which include various compounds and pharmacologic classes. The entities are interconnected through their roles in treating this specific type of cancer, highlighting the importance of these relationships in understanding treatment efficacy and options.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of Lymphatic System Cancer and the significant role of the associated compounds in treatment.\",\n    \"findings\": [\n        {\n            \"summary\": \"Lymphatic System Cancer as a central health concern\",\n            \"explanation\": \"Lymphatic System Cancer is a serious disease affecting the lymphatic system, necessitating effective treatment options. The presence of multiple treatment compounds indicates a robust community focused on addressing this health issue. The severity of this cancer type underscores the importance of ongoing research and development of effective therapies. [Data: Entities (363)]\"\n        },\n        {\n            \"summary\": \"Diverse treatment options available\",\n            \"explanation\": \"The community encompasses a variety of compounds used to treat Lymphatic System Cancer, including alkylating agents, nucleic acid synthesis inhibitors, and topoisomerase inhibitors. This diversity in treatment options is crucial for tailoring therapies to individual patient needs, enhancing the likelihood of successful outcomes. The relationships between these compounds and Lymphatic System Cancer highlight their collective importance in treatment protocols. [Data: Entities (364, 370, 371, 372, 373); Relationships (713, 715, 714)]\"\n        },\n        {\n            \"summary\": \"Role of Alkylating Activity in treatment\",\n            \"explanation\": \"Alkylating Activity is a significant pharmacologic class within this community, as it includes several compounds that are essential for treating Lymphatic System Cancer. The relationship between Lymphatic System Cancer and Alkylating Activity indicates a reliance on these compounds for effective treatment, emphasizing the need for ongoing research into their efficacy and safety. [Data: Entities (375); Relationships (713)]\"\n        },\n        {\n            \"summary\": \"Bleomycin's specific application\",\n            \"explanation\": \"Bleomycin is a compound specifically used to treat Lymphatic System Cancer, showcasing its importance in the therapeutic landscape. Its inclusion in treatment regimens highlights the need for understanding its mechanism of action and potential side effects, which are critical for optimizing patient care. [Data: Entities (366); Relationships (708)]\"\n        },\n        {\n            \"summary\": \"Impact of Vinca Alkaloids on treatment\",\n            \"explanation\": \"Vinca Alkaloids, including Vincristine, are part of the treatment arsenal for Lymphatic System Cancer. Their role in therapy underscores the importance of this pharmacologic class in managing the disease, and ongoing studies are necessary to evaluate their effectiveness and safety profiles. [Data: Entities (373); Relationships (716)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n363,LYMPHATIC SYSTEM CANCER,Lymphatic System Cancer is a type of disease that affects the lymphatic system and can be treated or palliated by various compounds.,14\n375,ALKYLATING ACTIVITY,No Description,1\n366,BLEOMYCIN,Bleomycin is a compound with no specific pharmacologic class that is used to treat Lymphatic System Cancer.,1\n364,CARMUSTINE,Carmustine is a compound classified as an alkylating agent that is used to treat Lymphatic System Cancer.,1\n370,CYTARABINE,Cytarabine is a compound classified as a nucleic acid synthesis inhibitor that is used to treat Lymphatic System Cancer.,1\n367,FLUDARABINE,Fludarabine is a compound with no specific pharmacologic class that is used to treat Lymphatic System Cancer.,1\n372,FOLIC ACID METABOLISM INHIBITORS,\"Folic Acid Metabolism Inhibitors is a pharmacologic class that includes Methotrexate, which is used to treat Lymphatic System Cancer.\",1\n365,TENIPOSIDE,Teniposide is a compound classified as a topoisomerase inhibitor that is used to treat Lymphatic System Cancer.,1\n369,MECHLORETHAMINE,Mechlorethamine is a compound classified as an alkylating agent that is used to treat Lymphatic System Cancer.,1\n371,TOPOSOMERASE INHIBITORS,Topoisomerase Inhibitors is a pharmacologic class that includes compounds like Teniposide and Mitoxantrone used to treat Lymphatic System Cancer.,1\n373,VINKA ALKALOIDS,\"Vinca Alkaloids is a pharmacologic class that includes Vincristine, which is used to treat Lymphatic System Cancer.\",1\n374,NUCLEIC ACID SYNTHESIS INHIBITORS,\"Nucleic Acid Synthesis Inhibitors is a pharmacologic class that includes Cytarabine, which is used to treat Lymphatic System Cancer.\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n439,MITOXANTRONE,LYMPHATIC SYSTEM CANCER,Mitoxantrone is used to treat Lymphatic System Cancer,24\n685,METHOTREXATE,LYMPHATIC SYSTEM CANCER,Methotrexate is used to treat Lymphatic System Cancer,17\n710,LYMPHATIC SYSTEM CANCER,VINCRISTINE,Vincristine is used to treat Lymphatic System Cancer,16\n713,LYMPHATIC SYSTEM CANCER,ALKYLATING ACTIVITY,Alkylating Activity includes compounds that are used to treat Lymphatic System Cancer,15\n708,LYMPHATIC SYSTEM CANCER,BLEOMYCIN,Bleomycin is used to treat Lymphatic System Cancer,15\n706,LYMPHATIC SYSTEM CANCER,CARMUSTINE,Carmustine is used to treat Lymphatic System Cancer,15\n712,LYMPHATIC SYSTEM CANCER,CYTARABINE,Cytarabine is used to treat Lymphatic System Cancer,15\n709,LYMPHATIC SYSTEM CANCER,FLUDARABINE,Fludarabine is used to treat Lymphatic System Cancer,15\n715,LYMPHATIC SYSTEM CANCER,FOLIC ACID METABOLISM INHIBITORS,Folic Acid Metabolism Inhibitors include compounds that are used to treat Lymphatic System Cancer,15\n707,LYMPHATIC SYSTEM CANCER,TENIPOSIDE,Teniposide is used to treat Lymphatic System Cancer,15\n711,LYMPHATIC SYSTEM CANCER,MECHLORETHAMINE,Mechlorethamine is used to treat Lymphatic System Cancer,15\n714,LYMPHATIC SYSTEM CANCER,TOPOSOMERASE INHIBITORS,Topoisomerase Inhibitors include compounds that are used to treat Lymphatic System Cancer,15\n716,LYMPHATIC SYSTEM CANCER,VINKA ALKALOIDS,Vinca Alkaloids include compounds that are used to treat Lymphatic System Cancer,15\n717,LYMPHATIC SYSTEM CANCER,NUCLEIC ACID SYNTHESIS INHIBITORS,Nucleic Acid Synthesis Inhibitors include compounds that are used to treat Lymphatic System Cancer,15\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}